Claims Deadline Extended for National Rexulti Class Action Settlement

The Superior Court of Québec has extended the deadline for individuals to file claims related to a national class action settlement involving the medication Rexulti.

The settlement, initially approved on November 13, 2025, covers all individuals in Canada who were prescribed and took Rexulti, along with their estates and family members. The total value of the settlement is CAD $4.75 million.

This extension provides additional time for eligible individuals to submit their claims. Class action settlements are designed to resolve numerous legal claims efficiently, reducing the burden on the court system and offering compensation to potentially affected parties.

Further details and instructions for submitting claims are available through a dedicated website established in conjunction with the court's decision. Litigation of this nature often addresses concerns related to pharmaceutical side effects or marketing practices.